Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents Sankhala K; Mita A; Kelly K; Mahalingam D; Giles F; Mita MTarget Oncol 2009[Apr]; 4 (2): 135-42Mammalian target of rapamycin (mTOR) has emerged as an important target for cancer therapy. Rapamycin has a distinct, well-documented toxicity profile and most of the toxicity data has been reported in patients with organ transplantation. Newer mTOR inhibitors have slightly different pharmacokinetic properties, yet they present toxicity profiles similar to rapamycin. Most of these toxicities are mild to moderate in severity and can be managed clinically by dose modification and supportive measures. Mucositis and pneumonitis are the most commonly reported toxicities, but they rarely lead to treatment discontinuation. Pathogenesis of pneumonitis is uncertain, but various hypotheses have been suggested, including cell-mediated immune response to the drug.|Animals[MESH]|Antineoplastic Agents/*adverse effects/therapeutic use[MESH]|Drug Hypersensitivity/*immunology[MESH]|Graft Rejection/drug therapy[MESH]|Humans[MESH]|Mucositis/chemically induced[MESH]|Neoplasms/*drug therapy/pathology[MESH]|Organ Transplantation[MESH]|Pneumonia/*chemically induced/diagnosis/immunology/physiopathology[MESH]|Prognosis[MESH]|Protein Kinases/*metabolism[MESH]|Sirolimus/*adverse effects/therapeutic use[MESH]|TOR Serine-Threonine Kinases[MESH]|Th1 Cells/immunology[MESH]|Th2 Cells/immunology[MESH]|Treatment Outcome[MESH] |
